We are live on ! Find out more
LAB icon

Standard BioTools
LAB

141 hedge funds and large institutions have $543M invested in Standard BioTools in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 45 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

13% more capital invested

Capital invested by funds: $480M → $543M (+$62.5M)

2.53% more ownership

Funds ownership: 73.23% → 75.76% (+2.5%)

5% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 22

2% less funds holding

Funds holding: 144 → 141 (-3)

11% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 45

21% less call options, than puts

Call options by funds: $72K | Put options by funds: $91K

Holders
141
Holders Change
-3
Holders Change %
-2.08%
% of All Funds
2.02%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
21
Increased
40
Reduced
45
Closed
22
Calls
$72K
Puts
$91K
Net Calls
-$19K
Net Calls Change
-$1.17M

Top Buyers

1
CC
Casdin Capital
New York
+$14.3M
2
HBWM
Hollow Brook Wealth Management
New York
+$10.8M
3
Morgan Stanley
Morgan Stanley
New York
+$4.53M
4
Northern Trust
Northern Trust
Illinois
+$3.19M
5
Charles Schwab
Charles Schwab
California
+$3.13M

Top Sellers

1
AIM
ARK Investment Management
Florida
-$7.3M
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$2.14M
3
NAMA
Nikko Asset Management Americas
New York
-$2.09M
4
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$2.08M
5
ICM
Invenomic Capital Management
Massachusetts
-$1.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIBC Private Wealth Group
126
CIBC Private Wealth Group
Georgia
$1.74K – – –
SCM
127
Sterling Capital Management
North Carolina
$1.73K +$1.75K +896 New
GRP
128
Global Retirement Partners
California
$1.7K – – –
FDCDDQ
129
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.07K -$3.69K -1,887 -77%
RIL
130
Rothschild Investment LLC
Illinois
$764 +$627 +320 +421%
EBA
131
Eagle Bay Advisors
New York
$542 – – –
Osaic Holdings
132
Osaic Holdings
Arizona
$511 -$44.1K -22,535 -99%
Russell Investments Group
133
Russell Investments Group
United Kingdom
$425 – – –
CPA
134
Capital Performance Advisors
California
$380 +$386 +197 New
PNC Financial Services Group
135
PNC Financial Services Group
Pennsylvania
$247 – – –
US Bancorp
136
US Bancorp
Minnesota
$224 +$227 +116 New
ACM
137
Aster Capital Management
United Arab Emirates
$114 +$116 +59 New
PA
138
Parallel Advisors
California
$71 – – –
FFA
139
Farther Finance Advisors
California
$44 -$18 -9 -28%
BTI
140
Blue Trust Inc
Georgia
$12 – – –
Federated Hermes
141
Federated Hermes
Pennsylvania
$4 +$4 +2 New
ICM
142
Invenomic Capital Management
Massachusetts
– -$1.68M -950,114 Closed
MF
143
Magnetar Financial
Illinois
– -$1.23M -692,998 Closed
GA
144
Gagnon Advisors
New York
– -$1.19M -672,294 Closed
Walleye Capital
145
Walleye Capital
New York
– -$994K -561,521 Closed
Assenagon Asset Management
146
Assenagon Asset Management
Luxembourg
– -$740K -417,917 Closed
RG
147
Redmile Group
California
– -$729K -411,631 Closed
AGM
148
Alpine Global Management
New York
– -$520K -293,706 Closed
ZDA
149
Zweig-DiMenna Associates
New York
– -$249K -140,535 Closed
RC
150
RBF Capital
California
– -$178K -100,572 Closed
3 4 5
6
7

LAB Hedge Fund Activity: Q3 2024 in Review

141 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2024, worth a combined $543M — up 13% from $480M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of LAB and 21 opened new positions — a net loss of 1 holder — while 45 trimmed existing stakes and 40 added.

The largest buyer was Casdin Capital, adding an estimated $14.3M. The largest seller was ARK Investment Management, cutting an estimated $7.3M.

  • 141 institutional investors held Standard BioTools (LAB) as of Q3 2024, down from 144 in Q2 2024.
  • Funds reported $543M of Standard BioTools stock for Q3 2024, up 13% quarter-over-quarter.
  • 21 funds opened new Standard BioTools positions in Q3 2024 and 22 closed out, a net change of -1 holder.
  • The largest Standard BioTools buyer in Q3 2024 was Casdin Capital, an estimated $14.3M added.
  • The largest Standard BioTools seller in Q3 2024 was ARK Investment Management, an estimated $7.3M sold.

Based on aggregated 13F filings for Q3 2024.